Business
Faron Appoints New Medical Director
Faron Appoints New Medical Director.
About this update from Faron Pharmaceuticals Oy
[{"type":"text","content":"\n \nRNS Number : 9490W Faron Pharmaceuticals Oy 03 May 2016 \n\nFaron Pharmaceuticals Ltd\n(\"Faron\" or the \"Company\")\n \nFaron Strengthens Executive Team by Appointing New Medical Director\nTURKU - FINLAND 3 May 2016 - Faron Pharmaceuticals Ltd (\"Faron\") (LON: FARN) announced today that it has strengthened its Executive Management Team with the appointment of MD, PhD, eMBA Matti Karvonen as its new Medical Director. Dr. Karvonen will be responsible for overseeing Faron's drug development strategy and will play a central role in expanding the clinical programmes of Traumakine® and Clevegen®.\nDr. Markku Jalkanen, CEO of Faron said: \"We are delighted to welcome Dr. Karvonen to our ambitious Executive Management Team. His appointment comes at an important time for Faron as we expand our clinical activities. Our lead drug candidate Traumakine, for the treatment of Acute Respiratory Distress Syndrome (ARDS) is now in a pan-European Phase III INTEREST trial, while clinical development for Clevegen, our novel cancer immunotherapy drug candidate is under active planning. Dr. Karvonen's experience in taking drugs through development programmes will provide an invaluable insight into the needs of both ARDS and cancer patients.\"\nDr. Karvonen has a background in clinical neurology with a deep medical experience in many international pharmaceutical organisations, including Roche, Biogen Idec and Novartis and has participated in many clinical programmes, most recently in the pan-European launch of a new neurological drug. In the early part of his career Dr. Karvonen held several research positions and he has also co-founded several commercial medical organisations.\n \nFor more information, please contact:\n \nFaron Pharmaceuticals Oy\nKatja Wallenlind\nPhone +358 (50) 577 4807 \nE-mail: [email protected]\n \nHume Brophy, PR\nMary Clark, Eva Haas, Hollie Vile\nPhone: +44 207 862 6390\nE-mail: [email protected]\n \nCairn Financial Advisers LLP, Nominated Adviser\nEmma Earl, Tony Rawlinson and Rebecca Anderson \nPhone: +44 207 148 7900\n \nPanmure Gordon (UK) Limited, Joint Broker\nFreddy Crossley, Duncan Monteith (Corporate Finance)\nTom Salvesen (Corporate Broking)\nPhone: +44 207 886 2500\n \nWhitman Howard Limited, Joint Broker\nRanald McGregor-Smith, Francis Nor...